AzTrials
AzTrials

Parkinson Disease, IdiopathicNCT07094828

Integration of Augmented Visual Feedback in Action Observation and Motor Imagery Therapy for Parkinson's Disease

A study testing AOMI with D-Wall and Routine physiotherapy with D-Wall in people with Parkinson Disease, Idiopathic, run by University of Bergamo.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Improving movement control during rehabilitation is still a challenge for people with Parkinson's Disease, mainly because of the motor symptoms caused by the condition. However, new technologies offer promising ways to support therapy. Read more about this study

Who is it for?
Ages 40 to 80 years
Conditions the study is for
Parkinson Disease, Idiopathic
What is being tested?
AOMI with D-Wall and Routine physiotherapy with D-Wall
Could I receive a placebo?
No, everyone receives an active treatment
How many people
86 participants
Where
No sites listed yet
Study dates
1 Sep 2025to Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • diagnosis of idiopathic Parkinson's disease for at least 5 years;
  • stable medication regimen for at least 4 weeks;
  • no cognitive impairment according to the Mini-Mental State Examination;
  • at stage ≤3 on the Hoehn \& Yahr scale;
  • provide informed consent to participate.

Who cannot join

  • undergoing advanced therapies (e.g., deep brain stimulation or infusion pump therapy);
  • unable to walk independently for at least 5 meters without assistive devices;
  • substance abuse;
  • with visual, orthopedic, or other medical conditions that could hinder the execution of activities;
  • history of other neurological disorders (other than Parkinson's disease).

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Inaihá L. Benincá, PhD student contact

+39034525111

inaiha.laureanobeninca@unibg.com

About this study

Official title: Integration of Augmented Visual Feedback Into Action Observation and Motor Imagery Therapy for Parkinson's Disease: A Randomized Controlled Trial

Improving movement control during rehabilitation is still a challenge for people with Parkinson's Disease, mainly because of the motor symptoms caused by the condition. However, new technologies offer promising ways to support therapy.

This clinical trial will test whether using TecnoBody® D-Wall technology integrated with two techniques (Action Observation and Motor Imagery) can improve physiotherapy outcomes for people with Parkinson's Disease.

Read more

The TecnoBody® D-Wall is a type of digital mirror that includes a 3D camera, pressure-sensitive platforms, and a screen. It shows a person's body movements in real time and gives visual feedback on joint mobility, balance, and how weight is distributed during movement.

Action Observation and Motor Imagery are two techniques already used in physiotherapy. Action Observation involves watching someone perform a movement, while Motor Imagery involves mentally rehearsing the movement before doing it. Studies have shown that both techniques activate the same brain areas involved in actual movement.

In this trial, after watching and imagining the movement, participants will perform the exercise in front of the D-Wall. This setup gives them real-time feedback to help improve how they move, a new approach for these techniques.

To see if this approach works, we will measure balance using a test validated for people with Parkinson's Disease and assess mobility using lab-based gait analysis, which tracks how a person walks.

Participants in the study will:

  • Be receiving routine physiotherapy at a hospital that is specialized in Parkinson's Disease rehabilitation.
  • Be randomly assigned to one of two groups: 1) One group will receive physiotherapy incorporating the D-Wall alongside Action Observation and Motor Imagery; 2) The other group will receive physiotherapy incorporating the D-Wall but, without Action Observation or Motor Imagery.
  • Take part in therapy for up to four weeks, followed by another four weeks of monitoring, for a total of up to two months.
  • Complete some initial tests to check if they are eligible for the study.

This study includes patients who have been diagnosed with idiopathic Parkinson's Disease and are undergoing rehabilitation as part of their usual hospital care. The intervention lasts as long as their regular hospital stay.

Being tested
AOMI with D-Wall, Routine physiotherapy with D-Wall
Keywords
Action Observation, Motor Imagery, Technology, Physiotherapy, Gait Analysis
Medical subject headings
Parkinson Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AOMI with D-WallOther

    Also called Action Observation and Motor Imagery integrated with D-Wall technology

    The intervention group will follow routine rehabilitative activity in the morning and will perform one hour of Action Observation and Motor Imagery training with augmented visual feedback (D-Wall) in the afternoon, three times a week.

    Each session will be conducted as follows: first AO (Action Observation), then MI (Motor Imagery). During the MI phase, participants will be asked to imagine the motor tasks and then perform them, receiving real-time augmented visual feedback provided by the digital mirror.

  • Routine physiotherapy with D-WallOther

    Also called Routine rehabilitative physiotherapy integrated with D-Wall technology

    The control group will also follow routine rehabilitative activity in the morning, while in the afternoon they will perform motor training of the same duration, without Action Observation and Motor Imagery, but solely with augmented visual feedback (D-Wall), with the same weekly frequency.

Study groups in NCT07094828
Study groupRoleWhat they receive
Action Observation and Motor Imagery integrated with D-Wall technologyExperimentalNot described
Receives: Other: AOMI with D-Wall
Routine rehabilitative physiotherapy integrated with D-Wall technologyActive comparatorNot described
Receives: Other: Routine physiotherapy with D-Wall

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dynamic postural control

    The Mini-Balance Evaluation Systems Test (Mini-BESTest) will be used to assess dynamic postural control.

    Measured: at baseline, at the fourth week (end of the intervention period), and at the eighth week (follow-up).

Secondary outcomes (1)
  1. Moviment analysis

    Secondary outcomes will be obtained through instrumented motion analysis. Specifically, it will include spatiotemporal parameters and descriptive measures of the kinematics and dynamics of the hip, knee, and ankle joints.

    Measured: at baseline, at the fourth week (end of the intervention period), and at the eighth week (follow-up).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jul 2025
  2. Study start1 Sep 2025 (estimated)
  3. Primary completionJun 2026 (estimated)
  4. Study completionJul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
86 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07094828
Sponsor's protocol ID
0026841/25
Status last verified
Jul 2025
First submitted
23 Jul 2025
Last updated
30 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing AOMI with D-Wall and Routine physiotherapy with D-Wall in people with Parkinson Disease, Idiopathic, run by University of Bergamo.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Inaihá L. Benincá, PhD student (+39034525111, inaiha.laureanobeninca@unibg.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dynamic postural control (time frame: at baseline, at the fourth week (end of the intervention period), and at the eighth week (follow-up).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in